Related Experiment Videos
Gastrografin treatment of intestinal obstruction due to Ascaris lumbricoides
Insights
Gastrografin effectively treats subacute intestinal obstruction in children caused by Ascaris lumbricoides. This treatment significantly reduces hospital stay and speeds up bowel movements compared to no treatment.
Area of Science:
- Pediatric Gastroenterology
- Parasitology
- Radiology
Background:
- Intestinal obstruction is a serious complication of Ascaris lumbricoides infections in children.
- Conservative management options are limited, often requiring surgical intervention.
Purpose of the Study:
- To evaluate the efficacy of Gastrografin in relieving subacute intestinal obstruction caused by Ascaris lumbricoides in pediatric patients.
- To compare clinical outcomes, including hospital stay and time to first bowel action, between Gastrografin-treated and untreated groups.
Main Methods:
- A cohort of children with subacute intestinal obstruction due to Ascaris lumbricoides was treated with Gastrografin.
- A control group of untreated patients was used for comparison.
- Statistical analysis was performed on hospital stay duration and time to first bowel action.
Main Results:
- Gastrografin demonstrated high efficiency in resolving the obstruction.
- The Gastrografin group showed a statistically significant shorter hospital stay compared to the control group.
- Patients treated with Gastrografin experienced a significantly earlier first bowel action.
Conclusions:
- Gastrografin is a highly effective treatment for subacute intestinal obstruction caused by Ascaris lumbricoides in children.
- The use of Gastrografin offers significant clinical benefits, including reduced hospital stay and faster recovery.
- Adequate hydration is crucial prior to Gastrografin administration for optimal outcomes.
Abstract:
Gastrografin was used to relieve subacute intestinal obstruction due to Ascaris lumbricoides in children. This hyperosmolar and wetting agent proved to be highly efficient to achieve this goal. Statistical evaluation of the hospital stay and first bowel action showed a significant difference between the treated "gastrografin group' and the untreated by gastrografin "control group,' in favor of the "gastrografin group.' Our data strongly suggest the use of Gastrografin in subacute intestinal obstruction due to Ascaris lumbricoides. This treatment should be instituted provided the patient has been adequately hydrated prior to administration.